Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

1. Gonçalves, J.
2. Santos, C.D.
3. Fresco, P.
4. Fernandez-Llimos, F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.REPC.2023.10.005 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus